EXPRESSION OF CYTOCHROME-P450 AND MICROSOMAL EPOXIDE HYDROLASE IN CERVICAL AND ORAL EPITHELIAL-CELLS IMMORTALIZED BY HUMAN PAPILLOMAVIRUS TYPE-16 E6/E7 GENES

被引:33
|
作者
FARIN, FM
BIGLER, LG
ODA, D
MCDOUGALL, JK
OMIECINSKI, CJ
机构
[1] UNIV WASHINGTON, SCH PUBL HLTH & COMMUNITY MED, DEPT ENVIRONM HLTH, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, FRED HUTCHINSON CANC RES CTR, DEPT PATHOL, SEATTLE, WA 98195 USA
[3] UNIV MISSISSIPPI, MED CTR, DEPT MED, DIV ONCOL, JACKSON, MS 39216 USA
[4] UNIV WASHINGTON, SCH DENT, DEPT ORAL BIOL, SEATTLE, WA 98195 USA
关键词
D O I
10.1093/carcin/16.6.1391
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidemiological evidence suggests that the presence of human papillomaviruses (HPV), when combined with smoking behaviors, considerably enhances the risk of developing oral, cervical, vulvar, and/or anal carcinomas. It is well established that the cytochrome P450 (CYP), microsomal epoxide hydrolase (mEH), and other biotransformation enzymes are important modulators of the bioactivation and detoxification of many environmental chemicals, including constituents of tobacco smoke such as certain nitrosamines and polycyclic aromatic hydrocarbons (PAH). Since there is little information regarding oral and cervical epithelial-specific expression of these genes, established primary and HPV-immortalized oral and cervical epithelial cell lines were analyzed for morphology, mRNA and protein expression patterns of specific CYPs and mEH. Primary human oral and cervical epithelial cells were immortalized using retroviral infection with HPV-16 E6/E7 genes. Primary human keratinocyte cells were immortalized by transfection of HPV-18 and made tumorigenic with nitrosomethylurea treatment. Expression profiles for mEH, CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2D6, CYP3A, and CYP2E1 were evaluated in these cultures in the presence or absence of a PAH inducer, using reverse transcriptase-coupled polymerase chain reaction analysis, mEH gene expression was evident in all cultures, while CYP2A6 mRNA was not detected in any of the cell lines, regardless of culture conditions, CYP2E1 mRNA expression was greatest in the oral epithelial cultures and detectable in all other epithelial cultures except for the HPV-18 immortalized keratinocyte cell line. Elevated levels of CYP2D6 mRNA existed in both oral epithelial cell lines and the HPV-16 immortalized cervical epithelial cells when compared to the other cell lines examined, CYP1A1 and CYP1A2 mRNAs were detected in all the cells and several cultures were inducible by PAH exposure. To corroborate the RT/PCR data, Western immunoblotting experiments were conducted on selected samples, Using these methods, CYP1A1 and CYP2E1 proteins were detected in primary and HPV-immortalized oral and cervical epithelial cultures, These data indicate that both primary and HPV immortalized cells appear to express certain biotransformation enzymes necessary for the activation of tobacco-specific nitrosamines and PAHs. Although the overall impact of HPV gene infection on expression of these systems remains to be fully elucidated, an in vitro system is characterized which should prove useful in examining interactive mechanisms of HPV with xenobiotic activation in the etiology of squamous cell carcinomas.
引用
收藏
页码:1391 / 1401
页数:11
相关论文
共 50 条
  • [41] Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation
    Magaldi, Thomas G.
    Almstead, Laura L.
    Bellone, Stefania
    Prevatt, Edward G.
    Santin, Alessandro D.
    DiMaio, Daniel
    [J]. VIROLOGY, 2012, 422 (01) : 114 - 124
  • [42] Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes
    DeFilippis, VR
    Ayala, FJ
    Villarreal, LP
    [J]. JOURNAL OF MOLECULAR EVOLUTION, 2002, 55 (04) : 491 - 499
  • [43] DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins
    Wlazlo, AP
    Deng, HY
    Giles-Davis, W
    Ertl, HCJ
    [J]. CANCER GENE THERAPY, 2004, 11 (06) : 457 - 464
  • [44] Evidence of Diversifying Selection in Human Papillomavirus Type 16 E6 But Not E7 Oncogenes
    Victor R. DeFilippis
    Francisco J. Ayala
    Luis P. Villarreal
    [J]. Journal of Molecular Evolution, 2002, 55 : 491 - 499
  • [45] DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins
    Anthony P Wlazlo
    Hongying Deng
    Wynetta Giles-Davis
    Hildegund C J Ertl
    [J]. Cancer Gene Therapy, 2004, 11 : 457 - 464
  • [46] MODULATION OF IMMORTALIZING PROPERTIES OF HUMAN PAPILLOMAVIRUS TYPE-16 E7 BY P53 EXPRESSION
    CROOK, T
    FISHER, C
    VOUSDEN, KH
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (01) : 505 - 510
  • [47] Expression of the E6 and E7 genes of human papillomavirus (HPV16) extends the life span of human myoblasts
    Lochmüller, H
    Johns, T
    Shoubridge, EA
    [J]. EXPERIMENTAL CELL RESEARCH, 1999, 248 (01) : 186 - 193
  • [48] Immortalization of human urothelial cells by human papillomavirus type 16 E6 and E7 genes in a defined serum-free system
    Carmean, N.
    Kosman, J. W.
    Leaf, E. M.
    Hudson, A. E.
    Opheim, K. E.
    Bassuk, J. A.
    [J]. CELL PROLIFERATION, 2007, 40 (02) : 166 - 184
  • [49] EXPRESSION OF THE L2 AND E7 GENES OF THE HUMAN PAPILLOMAVIRUS TYPE-16 IN FEMALE GENITAL DYSPLASIAS
    AUVINEN, E
    KUJARI, H
    ARSTILA, P
    HUKKANEN, V
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1992, 141 (05): : 1217 - 1224
  • [50] SEQUENCE VARIATION OF HUMAN PAPILLOMAVIRUS TYPE-16 E7 IN PREINVASIVE AND INVASIVE CERVICAL NEOPLASIAS
    FUJINAGA, Y
    OKAZAWA, K
    NISHIKAWA, A
    YAMAKAWA, Y
    FUKUSHIMA, M
    KATO, I
    FUJINAGA, K
    [J]. VIRUS GENES, 1994, 9 (01) : 85 - 92